EN
0
Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide hydrochloride hydrate (1:2:1)
N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide hydrochloride hydrate (1:2:1) structure, CAS 1374744-69-0

N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide hydrochloride hydrate (1:2:1)

CAS Number1374744-69-0

SynonymsUH9J2HBQWJ

Molecular FormulaC27H40Cl2N6O4S

Molecular Weight615.615

Purity

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1170829 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 1374744-69-0 ] SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number1374744-69-0
Catalog No.2A-1170829
Chinese NameFedratinib hydrochloride hydrate
SynonymsUH9J2HBQWJ
Molecular FormulaC27H40Cl2N6O4S
Molecular Weight615.615
ApplicationFedratinib hydrochloride hydrate (TG-101348 hydrochloride hydrate) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with an IC50 of 3 nM for both JAK2 and JAK2V617F kinase. Fed
PubChem ID272999643
SMILESCc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cl.Cl.O
InChIInChI=1S/C27H36N6O3S.2ClH.H2O/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4;;;/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31);2*1H;1H2
InChI KeyQAFZLTVOFJHYDF-UHFFFAOYSA-N
Transport InfoProduct name: N-(tert-butyl)-3-((5-methyl-2-((4-(2-pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide dihydrochloride hydrate
Related Products in Pharmaceutical Intermediates
(S)-1-Phenyl)prop-1-yl N,N-Diisopropylcarbamate1201898-70-52A-1170745
(R)-(-)-4-METHYLGLUTARIC ACID 1-MONOMETHYL ESTER80986-17-02A-1170771
(2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol163706-51-22A-1170782
(R)-2-(4-BUTYLPHENYL)-PROPIONIC ACID1263078-21-22A-1170799
3-[(R)-2-(N,N-dimethylamino)ethylthio-Sar]-4-(3-hydroxymethylleucine)cyclosporin210759-10-72A-1170807
(1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-carboxylate1246819-78-22A-1170862
(1S,4R)-4-[(2,5-DiaMino-6-chloro-4-pyriMidinyl)aMino]-2-cyclopentene-1-Methanol141271-11-62A-1170865
(5R)-5-(Chloromethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone496031-57-32A-1170883
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid hydrate (2:1)138199-71-02A-1170902
1-Azabicyclo[2.2.2]octan-3-ol, 3-acetate, (3R)-59653-40-62A-1170906
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA